CMIC supports clinical trials and manufacturing of influenza antiviral drugs
“Avigan® Tablet” and contributes to accelerating provision for COVID-19 patients
CMIC is your trusted service partner for the U.S., Japan and Asia.
With our extensive range of services, bredth and depth of expertise, and proven track record as the first Contract Research Oranization (CRO) in Japan, CMIC Group is your strategic partner for your entire drug development process.
Supporting nearly 80% of new drug development in Japan
With over 25 years of CRO expertise in Japan, as well as other services for drug development and commercialization, CMIC makes your success our focus.
Pharmaceutical Value Creator
Our PVC business model supports an entire value chain for pharmaceutical companies, including drug development, manufacturing, sales and marketing.
[Webinar] Mastering the Virtual Clinical Trial
Available OnDemand!
CMIC supports clinical trials and manufacturing of influenza antiviral drugs
“Avigan® Tablet” and contributes to accelerating provision for COVID-19 patients
CMIC is your trusted service partner for the U.S., Japan and Asia.
With our extensive range of services, bredth and depth of expertise, and proven track record as the first Contract Research Oranization (CRO) in Japan, CMIC Group is your strategic partner for your entire drug development process.
Supporting nearly 80% of new drug development in Japan
With over 25 years of CRO expertise in Japan, as well as other services for drug development and commercialization, CMIC makes your success our focus.
Pharmaceutical Value Creator
Our PVC business model supports an entire value chain for pharmaceutical companies, including drug development, manufacturing, sales and marketing.
Pharmaceutical Development Services
CMIC Group pioneered the CRO business in Japan over 28 years ago. Since then CMIC has continued as a leading innovator in the industry and has expanded services to encompass the entire pharmaceutical value-chain. We pride ourselves on meeting customers where they are and with exactly what they need to move their products forward. View our services below by selecting the phase of drug development that you are working in:
CMIC offers tailored solutions for pharmaceutical companies, medical device manufacturers, academia, bio-ventures and medical institutions. Using our collective strengths, we offer a broad range of services from preclinical research to practical applications.
Japanese Market Entry
Providing full pharmaceutical capabilities for overseas business partners to enter into Japan market.
Supporting our client’s clinical trials throughout the Asia Pacific region. Providing solutions for a range of therapeutic areas, registry study, observational study, phases II/III clinical trials, phase IV clinical trials, post-marketing surveillance.
Specialized oncology staff assists with strategic development planning, including regulatory interaction, conducting clinical studies and post-marketing promotion for companies that wish to enter into the field of oncology.
Established systems ready to implement and form development strategies and support every stage of the regenerative medicine lifecycle, including regulatory consulting, various nonclinical and clinical studies, and post-marketing.
OrphanPacific is a pharmaceutical company within CMIC Group, which provides wealth of experience in the field of orphan drugs: regulatory affairs, supply chain management, quality management and marketing strategy planning.
